Table 1 Patient demographics and clinical characteristics.

From: Biomarker characterization of clinical subtypes of Parkinson Disease

Variable

Whole cohort (n = 206)

Sex: Male

122 (59.2%)

Ethnicity:

 Chinese

177 (85.9%)

 Malay

11 (5.3%)

 Indian

14 (6.8%)

 Others

4 (2%)

 Education (Year)

10.6 ± 4.4

Age of diagnosis (year)

63.5 ± 9.0

PRS

0.7 (0.3–1.0)

Patients with RBD symptoms

51 (24.8%)

MCI

108 (52.4%)

Memory score

−1.0 (−1.9–0.2)

Visuospatial score

−0.5 (−1.2–0.2)

Attention score

−0.3 (−0.9–0.3)

Language score

−0.1 (−1.0–0.3)

Executive score

−0.2 (−0.8–0.4)

MDS-UPDRS part I score

3 (2–6)

MDS-UPDRS part II score

3 (1–6)

MDS-UPDRS part III score

20 (15–26)

PIGD score

1 (1–2)

Tremor score

3 (1–5)

HADS Anxiety Total score

2 (0–4)

HADS Depression Total score

2 (1–4)

NMSS Total score

14 (9–26)

LEDD

194.8 ± 138.0

  1. Categorical variables reported as frequency (%); continuous variables reported as mean ± standard deviation or median and first and third quartile, where appropriate.
  2. PRS polygenic risk score, RBD rapid eye movement sleep behaviour disorder, MCI mild cognitive impairment, MDS-UPDRS movement disorder society-unified Parkinson’s disease rating scale, PIGD postural instability and gait disorder, HADS Hospital Anxiety Depression Scale, NMSS Non-motor symptom scale, LEDD levodopa equivalent daily dose.
Back to article page